Mavik¿ trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Halo Pharmaceutical ...

FDA Drug Recall #D-901-2013 — Class III — August 1, 2013

Recall Summary

Recall Number D-901-2013
Classification Class III — Low risk
Date Initiated August 1, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm AbbVie Inc.
Location North Chicago, IL
Product Type Drugs
Quantity 704 bottles

Product Description

Mavik¿ trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ for Abbott Laboratories, North Chicago, IL 60064, USA

Reason for Recall

Labeling: Incorrect Package Insert; product packaged with outdated version of the insert

Distribution Pattern

Nationwide

Lot / Code Information

Lot 22033GY

Other Recalls from AbbVie Inc.

Recall # Classification Product Date
D-0664-2024 Class II Refresh P.M., (Mineral Oil 42.5%, White Petrola... Sep 16, 2024
D-0665-2024 Class II Refresh LACRI-LUBE, (42.5% Mineral Oil, 57.3% W... Sep 16, 2024
D-0088-2024 Class III Synthroid, Levothyroxine Sodium Tablets, USP 12... Oct 17, 2023
D-0412-2018 Class III Ultane (sevoflurane), 250 mL, Inhalation Anesth... Jan 22, 2018
D-0034-2018 Class III AndroGel (testosterone gel) 1.62%, 40.5mg in 2.... Sep 8, 2017

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.